why choose us

First received: September 14, 2023

Clinical Trial: Daratumumab for Polyneuropathy Associated With MGUS

Study Status: Completed

Recruit Status: RECRUITING

Condition: Peripheral Neuropathy

Study Type: INTERVENTIONAL


Official Title: Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS

Brief Summary: The goal of this clinical trial is to learn about daratumumab and hyaluronidase-fihj in patients with monoclonal gammopathy of undetermined significant (MGUS) who have been diagnosed with peripheral neuropathy suspected to be cause by paraproteinemia.The main question[s] it aims to answer are:• how well does this medication help improve MGUS associated peripheral neuropathyParticipants will be asked be asked to get some testing done prior to starting the trial in order for us to assess your nerve damage or…

Read more